Content |
Assets
History
2020: Grail purchase
At the end of September, 2020 Illumina announced acquisition of the Grail company which earlier separated from it. According to the agreement, shareholders of Grail will receive the total amount of remuneration in the amount of $8 billion from which $3.5 billion will arrive from own means of the buyer, and $4.5 billion will be provided in the form of stocks of Illumina on the security. According to the press release, Illumina owns 14.5% of issued shares of Grail now. Read more here.
2018: Purchase of the developer of the equipment for interpretation of Pacific Biosciences DNA for $1.2 billion
At the beginning of November, 2018 Illumina announced purchase of Pacific Biosciences for $1.2 billion. Thus, the leading equipment manufacturers for DNA interpretation integrate. Execute all formalities concerning this transaction including get approvals of regulators, it is planned to the middle of 2019. Read more here.